Abstract P2-20-02: Site of recurrence after neoadjuvant therapy: Clues to biology and impact on endpoints
Christina Yau(Hospital Authority), Laura J. Esserman(University of California, San Francisco), Tara Sanft(Yale Cancer Center), Angela DeMichele(University of Pennsylvania), Jodi M. Carter(University of Alberta), Richard B. Schwab(Center for Personalized Cancer Treatment), Laura van ‘t Veer, Erin D. Ellis(University of Hawaii Cancer Center), Lajos Pusztai(Yale University), Qamar J. Khan(University of Kansas Medical Center), Rachel L. Yung(Seattle Cancer Care Alliance), Janice Lu(University of Southern California), Judy C. Boughey(Mayo Clinic in Arizona), Douglas Yee(University of Minnesota Medical Center), Nola M. Hylton(University of California, San Francisco), Julie E. Lang(University of Southern California), Erica Stringer-Reasor(University of Alabama at Birmingham), Laila Khazai(Moffitt Cancer Center), David Euhus(The University of Texas Southwestern Medical Center), Sunati Sahoo(The University of Texas Southwestern Medical Center), Kimberly Cole(Yale University), Kirsten K. Edmiston(Virginia Cancer Institute), Donald W. Northfelt(Mayo Clinic in Arizona), Yunn‐Yi Chen(University of Vermont), A. Jo Chien(University of California, San Francisco), Kathy S. Albain(Loyola University Chicago), Amy S. Clark(Abramson Center for Jewish Life), Rebecca K. Viscusi(University of Arizona), Jeffrey B. Matthews(University of California, San Francisco), Christos Hatzis(University of Crete), Dina Kokh(University of Alabama at Birmingham), Claudine Isaacs(Georgetown University), Jane Perlmutter(Gemini Computers (United States)), Donald A. Berry(Berry & Associates (United States)), Jane Meisel(Emory University), Hope S. Rugo(City of Hope), Anne M. Wallace(University of California San Diego), Anthony Elias(University of Colorado Cancer Center), Gregor Krings(Cleveland Clinic), Molly Klein(University of Minnesota), Rita Nanda(University of Chicago Medical Center), Zaha Mitri(Oregon Health & Science University), Michelle Melisko(University of California, San Francisco), Heather Han(University of California, San Francisco), W. Fraser Symmans(The University of Texas MD Anderson Cancer Center)
Cited by 2
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k